Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Feng‐Ting Dao"'
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Leukemia cell-intrinsic somatic mutations and cytogenetic abnormalities have been used to define risk categories in acute myeloid leukemia (AML). In addition, since the immune microenvironment might influence prognosis and somatic mutations
Externí odkaz:
https://doaj.org/article/a500ffad68044c92bba0e233c3e35f84
Autor:
Lu Yang, Wen‐Min Chen, Feng‐Ting Dao, Yan‐Huan Zhang, Ya‐Zhe Wang, Yan Chang, Yan‐Rong Liu, Qian Jiang, Xiao‐Hui Zhang, Kai‐Yan Liu, Xiao‐Jun Huang, Ya‐Zhen Qin
Publikováno v:
Cancer Medicine, Vol 8, Iss 12, Pp 5459-5467 (2019)
Abstract Acute myeloid leukemia (AML) with t(8;21) is a heterogeneous disease. Although the detection of minimal residual disease (MRD), which is indicated by RUNX1‐RUNX1T1 transcript levels, plays a key role in directing treatment, risk stratifica
Externí odkaz:
https://doaj.org/article/8133eeceecc54d118380ccc021c99bbc
Autor:
Ya-Zhen Qin, Qian Jiang, Lan-Ping Xu, Yu Wang, Hao Jiang, Feng-Ting Dao, Wen-Min Chen, Xiao-Su Zhao, Yan-Rong Liu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Novel recurrent fusion gene types such as zinc finger protein 384 (ZNF384) fusions have been identified in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with the application of next-generation sequencing technologies. However, the comprehen
Externí odkaz:
https://doaj.org/article/72bfff6b167c4e1f9373bd0f5471e241
Autor:
Jun Wang, Feng‐Ting Dao, Yu Wang, Hao Jiang, Lan‐Ping Xu, Xiao‐Su Zhao, Xiao‐Hui Zhang, Kai‐Yan Liu, Xiao‐Jun Huang, Qian Jiang, Ya‐Zhen Qin
Publikováno v:
Hematological Oncology. 40:724-733
Although several studies have investigated the benefits of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for patients with inv (16) acute myeloid leukemia (AML) in first complete remission (CR1) individually stratified by KIT or FMS-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f14bdfeb9fc79680957f7196f428425f
https://doi.org/10.1002/hon.3015
https://doi.org/10.1002/hon.3015
Autor:
Hao Jiang, Ya-Zhe Wang, Feng-Ting Dao, Yan Chang, Nan Xu, Lu Yang, Ya-Zhen Qin, Wen-Min Chen, Yan-Rong Liu, Qian Jiang, Jun Wang
Publikováno v:
Leukemia & Lymphoma. 63:152-161
Acute myeloid leukemia (AML) with t(8;21) is a heterogeneous disease and needs to be stratified. Both, cancer cells and immune cells participate in tumor initiation, growth and progression and might affect clinical outcomes. TIM-3 (T cell immunoglobu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff2fe2a64f6ba31fec5befd1792b212a
https://doi.org/10.1080/10428194.2021.1966785
https://doi.org/10.1080/10428194.2021.1966785
Autor:
Jun Wang, Xiao-Hui Zhang, Ya-Zhen Qin, Lu Yang, Ling-Yu Long, Hao Jiang, Qian Jiang, Yan-Rong Liu, Ling-Di Li, Wen-Min Chen, Feng-Ting Dao
Publikováno v:
Leukemia & Lymphoma. 62:185-193
Acute myeloid leukemia with intermediate cytogenetic risk (ICR-AML) needs to be stratified and abnormal gene expression might be prognostic. PR/SET domain 16 (PRDM16) transcript levels were assesse...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87973583ba11d0ee00968cca2286193b
https://doi.org/10.1080/10428194.2020.1817436
https://doi.org/10.1080/10428194.2020.1817436
Autor:
Ya-Zhe Wang, Yan Chang, Ling-Di Li, Jin Lu, Ya-Zhen Qin, Ling-Yu Long, Yan-Rong Liu, Kai-Yan Liu, Lu Yang, Feng-Ting Dao, Wen-Min Chen
Publikováno v:
OncoTargets and Therapy. 13:7545-7553
Purpose The cancer-testis antigen, which is a preferentially expressed antigen of melanoma (PRAME), is an ideal target for immunotherapy and cancer vaccines. Since the expression of this antigen is relevant to therapy responses, the heterogeneity in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baa0c0a0cb8011df030248891c5f1261
https://doi.org/10.2147/ott.s240979
https://doi.org/10.2147/ott.s240979
Autor:
Yan Chang, Ya-Zhe Wang, Yan-Rong Liu, Yan-Huan Zhang, Xiao-Hui Zhang, Ya-Zhen Qin, Wen-Min Chen, Kai-Yan Liu, Feng-Ting Dao, Qian Jiang, Xiao-Jun Huang, Lu Yang
Publikováno v:
Cancer Medicine, Vol 8, Iss 12, Pp 5459-5467 (2019)
Cancer Medicine
Cancer Medicine
Acute myeloid leukemia (AML) with t(8;21) is a heterogeneous disease. Although the detection of minimal residual disease (MRD), which is indicated by RUNX1‐RUNX1T1 transcript levels, plays a key role in directing treatment, risk stratification need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55995ba593c6ccb574624ac9b7ef5faf
https://doi.org/10.1002/cam4.2422
https://doi.org/10.1002/cam4.2422
Autor:
Yan-Rong Liu, Lu Yang, Ai-Dong Lu, Wen-Min Chen, Le-Ping Zhang, Kai-Yan Liu, Ling-Di Li, Feng-Ting Dao, Ling-Yu Long, Ya-Zhen Qin
Publikováno v:
Pediatric hematology and oncology. 39(2)
Abnormally high ecotropic viral integration site 1 (EVI1) expression has been recognized as a poor prognostic factor in acute myeloid leukemia patients. However, its prognostic impact in B cell precursor acute lymphoblastic leukemia (BCP-ALL) remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ebc75985ef3ff3aba5df59bce9631b
https://pubmed.ncbi.nlm.nih.gov/34156313
https://pubmed.ncbi.nlm.nih.gov/34156313
Autor:
Feng-Ting Dao, Hao Jiang, Xiao-Jun Huang, Kai-Yan Liu, Xiao-Hui Zhang, Ya-Zhen Qin, Qian Jiang, Lan-Ping Xu, Yu Wang, Wen-Min Chen, Yan-Rong Liu, Xiao-Su Zhao
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Novel recurrent fusion gene types such as zinc finger protein 384 (ZNF384) fusions have been identified in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with the application of next-generation sequencing technologies. However, the comprehen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0c6dc4be32e96a1c83b458889d1c752
https://doi.org/10.3389/fonc.2021.632532
https://doi.org/10.3389/fonc.2021.632532